INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Performance Of Mobius® Bag Assemblies With Ultimus® Film In Truck Shipping Simulation Test

  Explore findings from a study testing Mobius® single-use bags under rigorous shipping conditions, demonstrating the suitability for transporting various liquid volumes while preserving their integrity.

• GLP-1 INJ Solid Phase Peptide Synthesis (SPPS) Workflow

  Scale your GLP-1 peptide synthesis efficiently. Discover how automated solid-phase workflows and single-use fluidics maximize crude purity while reducing total solvent consumption.

• Windsor Framework: What Is It?

  Learn about the Windsor Framework and how it addresses the challenges of medicine supply chains between the UK and the EU, creating stability and certainty in the post-Brexit world.

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.

• Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

  1/22/2025

  Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

• From LAL To rFC: The Evolution Of Endotoxin Testing

  6/26/2026

  Protect patient safety and ensure regulatory compliance by implementing sensitive, reliable bacterial endotoxin testing as a critical component of pharmaceutical quality assurance.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  6/9/2025

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• The Importance Of Quality In Raw Material Selection

  1/16/2025

  Learn how to select high-quality raw materials for cell-based manufacturing in this exploration of the criticality of raw materials, from preclinical development to commercialization. 

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.